scorecardresearch
Add as a preferred source on Google
Sunday, November 9, 2025
TopicAstraZeneca

Topic: AstraZeneca

UK asks regulator to approve Oxford-AstraZeneca vaccine for temporary supply

If authorised, the UK will be one of the first countries in the world to receive the vaccine. AstraZeneca expects to have up to 4 million doses ready by the end of 2020.

AstraZeneca plans another Covid vaccine trial to clear uncertainty and confusion

Questions are mounting over AstraZeneca vaccine after it said a lower dosage level that appeared more effective resulted from a manufacturing discrepancy.

AstraZeneca Covid vaccine effective, Indian trials running smoothly, says Serum Institute

The comments came after AstraZeneca & Oxford University acknowledged a manufacturing error that is raising doubts about preliminary results of their experimental Covid-19 vaccine.

AstraZeneca faces more questions on Oxford Covid vaccine after manufacturing error

While AstraZeneca earlier showed 70% efficacy on average in a late-stage study, the scant details released by the UK partners raises doubts on whether US regulators will clear it.

AstraZeneca Covid vaccine’s 90% efficacy came in younger trial group

The vaccine was 90% effective when a half-dose was given before a full-dose booster. However, that regime was administered to participants in a group whose age was capped at 55.

Key questions & answers about AstraZeneca-Oxford vaccine India could get

As findings of Astra-Oxford's Covid vaccine early trial results don't seem straightforward, questions are being raised if people will get vaccines with differing upfront efficacy.

Astra-Oxford delivers on Covid vaccine, but can’t match rivals Pfizer & Moderna

AstraZeneca and Oxford are taking a different vaccine approach from the one used by Pfizer and Moderna. Here's what the results could mean in the battle.

KCR’s free water sop a cynical pre-poll move. Politicians must first deliver and then seek votes

ThePrint view on the most important issues, instantly.

India to get 10 crore shots of AstraZeneca’s Covid vaccine by next month

If final-stage trial data show AstraZeneca’s candidate gives effective protection, Serum Institute of India may get emergency authorization by December.

AstraZeneca cancer drug fails to help hospitalised Covid patients

The UK drugmaker said the group of patients taking the cancer drug Calquence in addition to standard care didn’t show fewer deaths or respiratory failures.

On Camera

Moon madness has taken over modern dating. A waning crescent is the best time to ghost

Alongside buying into the grift that is dating apps, the girlies are also installing astrology apps like Astrotalk to investigate the same tired mystery—will he ever text back?

Africa’s blue economy is booming. What it can learn from Asia

Aquaculture is the fastest growing food sector in Africa, offering significant returns on investment for all involved and achieving the continent’s goals for food security, dignified livelihoods and economic growth.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.